Amrutanjan Health Care Limited (NSE: AMRUTANJAN)
India
· Delayed Price · Currency is INR
693.30
+13.00 (1.91%)
Jan 22, 2025, 3:30 PM IST
Amrutanjan Health Care Revenue
Amrutanjan Health Care had revenue of 1.10B INR in the quarter ending September 30, 2024, with 10.68% growth. This brings the company's revenue in the last twelve months to 4.38B, up 16.68% year-over-year. In the fiscal year ending March 31, 2024, Amrutanjan Health Care had annual revenue of 4.21B with 10.96% growth.
Revenue (ttm)
4.38B
Revenue Growth
+16.68%
P/S Ratio
n/a
Revenue / Employee
6.91M
Employees
634
Market Cap
19.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
Mar 31, 2021 | 3.33B | 712.64M | 27.23% |
Mar 31, 2020 | 2.62B | 82.23M | 3.24% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 503.08B |
Divi's Laboratories | 86.14B |
Cipla | 262.64B |
Mankind Pharma | 110.18B |
Apollo Hospitals Enterprise | 204.69B |
Zydus Lifesciences | 214.84B |
Aurobindo Pharma | 302.95B |
Alkem Laboratories | 128.32B |